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LETTER TO THE EDITOR
Elective endotracheal intubation for
urgent gastrointestinal endoscopy
among hospitalized patients with
SARS-CoV-2
To the Editor:
The most devastating consequence of the novel coronavirus disease (COVID-19) is respiratory failure. Mechanical
ventilation with endotracheal (ET) intubation in this setting
is associated with a poor prognosis.1 Still, many patients
require urgent procedures during hospitalization for
COVID-19 necessitating anesthesia and ET intubation.
However, whether extubation is readily feasible among patients hospitalized with COVID-19 with potential pulmonary involvement is unknown. The primary aim of this
study was to determine the feasibility of extubation after
elective intubation for GI endoscopy among patients hospitalized with COVID-19.
We present a case series of prospectively collected
endoscopy data from April 1, 2020, to May 12, 2020,
from 4 tertiary care hospitals within the Northwell Health
System in New York. Consecutive hospitalized patients
were included if (1) patient’s age was >18 years, (2) patient
was conﬁrmed positive for COVID-19, and (3) urgent GI
endoscopy was required. Only emergent or urgent cases
were performed during this time according to GI society
guidelines.2,3 This study was approved by the Zucker
School of Medicine/Northwell Health System Institutional
Review Board.
Patients were considered positive for COVID-19 if their
test results were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by polymerase chain reaction testing of nasopharyngeal samples
within 2 days of the procedure. Administration of supplemental oxygenation in COVID-19 patients was standardized
throughout Northwell in a protocol. If the oxygen saturation was below 94% on room air, nasal cannula oxygen
was given. If the oxygen saturation was below 94% on
maximum nasal cannula support, a nonrebreather mask
was used. If the patient was desaturating and in respiratory
distress with the nonrebreather and in the prone position,
an ET tube was placed.
The anesthesia type was at the discretion of the anesthesiologist and based on standard of care for each hospital. The
decision for ET intubation was based on the ability to protect
the airway against aspiration once the patient was sedated.
However, in general, patients with hematemesis, vomiting,
or GI lumen obstruction and those undergoing ERCP (given
the patient was placed prone) had ET intubation. The data
were analyzed by type of anesthesia: (1) elective ET intubation just before the endoscopy, (2) ET intubation for respirawww.giejournal.org

tory failure during the hospitalization, or (3) sedation with
monitored anesthesia care. The main outcome was the
rate of extubation just after the procedure in the elective
ET intubation group.
The SAS statistical software version 9.4 (SAS Institute,
Cary, NC, USA) was used to conduct all statistical tests.
The c2 test or Fisher exact test was used to compare categoric data, and the Student t test was used to compare
continuous data. A P value of < .05 was considered statistically signiﬁcant.
A total of 111 patients with COVID-19 were included in the
study period during the COVID-19 pandemic. Table 1 lists the
patient and procedure characteristics between the groups.
Patient age, gender, body mass index, comorbidities, and
indications were similar between groups.
Forty-ﬁve patients (45/111, 41%) underwent elective ET
intubation. All patients but 1 were receiving oxygen by nasal
cannula (98%, 44/45). One patient required a 100% nonrebreather mask. Thirty-eight percent of the patients (17/45)
had chest radiograph ﬁndings indicating pulmonary involvement of COVID-19. Of the 45 patients, 98% (44/45) were extubated safely after the procedure. One patient had
prolonged ET placement but was able to be extubated after
3 days. This patient was receiving nasal cannula oxygen
before the procedure. All patients remained extubated after
the procedure without respiratory adverse events (patients’
charts abstracted until 72 hours after the procedure).
Twenty-nine (29/111, 26%) patients had an ET already in
place for respiratory failure before endoscopy. Nine patients
were extubated and remain ET tube free, 5 patients died in
this group of COVID-related causes, 5 remain with an ET
tube, and 10 underwent tracheostomy. Thirty-seven (37/
111, 33%) underwent sedation with monitored anesthesia
care safely without respiratory adverse events. Forty-nine
percent of the patients (18/37) had chest radiograph ﬁndings
indicating pulmonary involvement of COVID-19. None of
these patients required ET intubation during the procedure.
Our study has limitations. These data are applicable only
to tertiary care centers. In addition, there was a lack of
standardization of who received elective general anesthesia
versus sedation among the 4 hospitals because that choice
was based on the discretion of the anesthesiologist and
standard of care at each hospital. However, this was mainly
based on the ability to protect the airway against aspiration, and thus per standard practice, in most institutions.
In conclusion, endoscopy can be a lifesaving procedure
for indications that are urgent or emergent in patients with
COVID-19. Often these procedures require ET intubation,
of which the pulmonary risk was previously unknown in
this cohort. This series shows that elective ET placement
in patients with COVID-19 appears to be well tolerated
and removable shortly after the procedure for the majority
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TABLE 1. Characteristics of 111 COVID-19 patients undergoing urgent GI endoscopy

Characteristic

All patients

Patients intubated
for respiratory distress
before endoscopy (n [ 29)

Average age, years (%)

63.5 (16.74)

64.5 (13.60)

61.6 (19.79)

65.2 (15.01)

.36

32.4 (36)

24.1 (7)

33.3 (15)

37.8 (14)

.67

White

37.3 (41)

41.4 (12)

45.5 (20)

24.3 (9)

Black

22.7 (25)

17.2 (5)

25.0 (11)

24.3 (9)

Gender female, % (n)

Patients electively
intubated (n [ 45)

Patients with
sedation (n [ 37)

P value

Race, % (n)

.005

Asian

10.9 (12)

13.8 (4)

0.00 (0)

21.6 (8)

Multiracial/other

29.1 (32)

27.6 (8)

29.6 (13)

29.7 (11)

BMI (SD)

29.9 (9.4)

29.4 (6.7)

32.2 (11.3)

27.7 (8.3)

.06

Charlson Comorbidity
Index, average (SD)

4.28 (3.0)

3.69 (2.5)

4.04 (3.0)

5.03 (3.3)

.16

DM

39.6 (44)

48.3 (14)

44.4 (20)

27.0 (10)

.10

HTN

57.7 (64)

62.1 (18)

60.0 (27)

51.4 (19)

.43

CAD

16.2 (18)

13.8 (4)

11.1 (5)

24.3 (9)

.11

CHF

9.0 (10)

6.9 (2)

8.9 (4)

10.8 (4)

1.00

COPD

8.1 (9)

10.3 (3)

8.9 (4)

5.4 (2)

.69

Smoking

5.4 (6)

0 (0)

8.9 (4)

5.4 (2)

.69

Asthma

1.8 (2)

0 (0)

4.4 (2)

0 (0)

.50

OSA

0.9 (1)

0 (0)

0 (0)

2.7 (1)

.45

Cirrhosis

3.6 (4)

3.5 (1)

0 (0)

8.1 (3)

.09

Prior GI bleeding

7.2 (8)

0 (0)

4.4 (2)

16.2 (6)

.13

Comorbidities, % (n)

Kidney disease

15.3 (17)

6.9 (2)

17.8 (8)

18.9 (7)

.89

Cancer

18.9 (21)

13.8 (4)

17.8 (8)

24.3 (9)

.47

Abnormal CXR, % (n)

55.9 (62)

93.1 (27)

37.8 (17)

48.7 (18)

.32

Patient in ICU, % (n)

38.7 (43)

93.1 (27)

26.7 (12)

10.8 (4)

.07

ASA class, % (n)

.61

1

3.6 (4)

0.00 (0)

6.7 (3)

2.7 (1)

2

5.4 (6)

0.00 (0)

8.9 (4)

5.4 (2)

3

46.9 (52)

10.3 (3)

53.3 (24)

67.6 (25)

4

44.1 (49)

89.7 (26)

31.1 (14)

24.3 (9)

73.0 (81)

0 (0)

97.8 (44)

100 (37)

1.00

0.9 (1)

0 (0)

2.2 (1)

0.00 (0)

1.00

26.1 (29)

100 (29)

0 (0)

0 (0)

N/A

Oxygenation status
before procedure, % (n)
Nasal cannula
Nonrebreather
ET tube for respiratory failure

Continuous variables are represented as means (SD), and categoric variables are represented as % (n).
ASA, American Society of Anesthesiologists Classification class; BMI, body mass index; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive lung
disease; CXR, chest x-ray; DM, diabetes mellitus; ET, endotracheal; HTN, hypertension; ICU, intensive care unit; OSA, obstructive sleep apnea.

of patients who require nasal cannula oxygen supplementation before the GI endoscopy procedure.
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